JWM
GMAB icon

Janiczek Wealth Management’s Genmab GMAB Stock Holding History

Janiczek Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-370
Closed -$11.1K – 1102
2024
Q1 		$11.1K Buy
+370
New +$10.9K ﹤0.01% 664
2023
Q1 		– Sell
-90
Closed -$3.6K – 1035
2022
Q4 		$3.6K Buy
+90
New +$3.71K ﹤0.01% 706
2022
Q1 		– Sell
-20
Closed -$1K – 998
2021
Q4 		$1K Hold
20
– – ﹤0.01% 918
2021
Q3 		$1K Hold
20
– – ﹤0.01% 892
2021
Q2 		$1K Buy
+20
New +$772 ﹤0.01% 843
2021
Q1 		– Sell
-90
Closed -$4K – 870
2020
Q4 		$4K Buy
+90
New +$3.36K ﹤0.01% 621
2020
Q3 		– Sell
-47
Closed -$2K – 673
2020
Q2 		$2K Buy
+47
New +$1.28K ﹤0.01% 281

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janiczek Wealth Management's GMAB Position: Q2 2024 in Review

Janiczek Wealth Management sold out of Genmab (GMAB) in Q2 2024, closing a stake of 370 shares — an estimated $11.1K sold.

Janiczek Wealth Management first reported a position in GMAB in Q2 2020 and held it in 7 quarters. The position peaked at $11.1K in Q1 2024. 219 funds tracked by Wall St. Rank hold GMAB as of Q2 2024.

  • Janiczek Wealth Management reported no remaining Genmab position as of Q2 2024 after selling out during the quarter.
  • Janiczek Wealth Management sold 370 Genmab shares in Q2 2024, an estimated $11.1K.
  • Janiczek Wealth Management first reported a position in Genmab in Q2 2020 and held it in 7 quarters.
  • Janiczek Wealth Management's Genmab position peaked at $11.1K in Q1 2024.
  • 219 funds tracked by Wall St. Rank held Genmab as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.